Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: Synergistic anticancer activity of cisplatin combined with tannic acid enhances apoptosis in lung cancer through the PERK-ATF4 pathway

Fig. 1

CDDP and TA inhibited GLC-82 and H1299 cell growth in vitro. GLC-82 (A) and H1299 cells (B) were treated with CDDP, TA, CDDP + TA for 24 h. MTT analysis indicated that CDDP and TA inhibited Lung cancer cell growth in a dose-dependent manner after 24 h, respectively. A combination of CDDP and TA synergistically inhibited cell growth. Experiments were performed in triplicate. *P < 0.05 and **P < 0.01, untreated control group vs. the TA- or CDDP-treated group, respectively; ##P < 0.01, the TA- or CDDP-treated group vs. the TA + CDDP group

Back to article page